4.7 Article

Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection

Journal

ANTIVIRAL RESEARCH
Volume 92, Issue 2, Pages 369-371

Publisher

ELSEVIER
DOI: 10.1016/j.antiviral.2011.08.003

Keywords

Glucosidase inhibitor; Dengue virus; Lethal infection mouse model

Funding

  1. NIH [AI061441, AI084267-0109]
  2. Hepatitis B Foundation, Commonwealth of Pennsylvania

Ask authors/readers for more resources

Dengue virus infection causes diseases in people, ranging from the acute febrile illness dengue fever, to life-threatening dengue hemorrhagic fever/dengue shock syndrome. We previously reported that a host cellular alpha-glucosidases I and II inhibitor, imino sugar CM-10-18, potently inhibited dengue virus replication in cultured cells, and significantly reduced viremia in dengue virus infected AG129 mice. In this report we show that CM-10-18 also significantly protects mice from death and/or disease progress in two mouse models of lethal dengue virus infection. Our results thus provide a strong support for the development of CM-10-18 or its derivatives as antiviral agents to treat servere dengue virus infections. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available